Nasdaq:US$14.85 (+0.00) | HKEX:HK$23.20 (-0.30) | AIM:£2.30 (+0)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Anti-tumour activity of Epitinib in patient derived esophagus cancer models